Reply to Scalone and Cortesi: "Cost-utility analysis of biologic therapies to treat chronic plaque psoriasis in Italy: the importance of using updated and adequate social tariffs to calculate QALYs"

BioDrugs. 2015 Feb;29(1):71-2. doi: 10.1007/s40259-015-0118-5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biological Therapy / economics*
  • Female
  • Humans
  • Male
  • Psoriasis / drug therapy*
  • Psoriasis / economics*